Quadrivalent versus trivalent influenza vaccine: clinical outcomes in two influenza seasons, historical cohort study
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Clinical Microbiology and Infection
- Vol. 26 (1) , 101-106
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adultsBMC Infectious Diseases, 2013
- A Randomized Trial of Candidate Inactivated Quadrivalent Influenza Vaccine versus Trivalent Influenza Vaccines in Children Aged 3–17 YearsThe Journal of Infectious Diseases, 2013
- The economic value of a quadrivalent versus trivalent influenza vaccineVaccine, 2012
- Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccineVaccine, 2012
- The rationale for quadrivalent influenza vaccinesHuman Vaccines & Immunotherapeutics, 2012
- Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete exampleBMC Infectious Diseases, 2009
- Long time trends in influenza-like illness and associated determinants in The NetherlandsEpidemiology and Infection, 2008
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Influenza A and B Virus Infections in ChildrenClinical Infectious Diseases, 2003
- Mortality Associated With Influenza and Respiratory Syncytial Virus in the United StatesJAMA, 2003